Navigation Links
DelMar Pharmaceuticals Announces Appointment of John K. Bell to Board of Directors
Date:2/28/2013

VANCOUVER, British Columbia and MENLO PARK, Calif., Feb. 28, 2013 /PRNewswire/ -- DelMar Pharmaceuticals, Inc. (OTCQB: DMPI) ("DelMar") is pleased to announce the appointment of Mr. John K. Bell to the company's Board of Directors.

John K. Bell , is Chairman of Onbelay Capital Inc., a Canadian based private equity Company with principal investments in Telematics and auto parts manufacturing (for past 5 years). Prior to that, from 1996 to 2005, Mr. Bell was CEO and owner of Polymer Technologies Inc., an automotive parts manufacturer. Prior to that, from 1977 to 1995, Mr. Bell was founder and owner of Shred-Tech Limited a global manufacturer and supplier of industrial shredders and mobile document shredders. Mr. Bell served as interim CEO and director of ATS Automation Tooling Systems in 2007. Mr. Bell is a director of BSM Wireless, Strongco Corporation, and the Royal Canadian Mint. Mr. Bell is National secretary and board member of The Crohns and Colitis Foundation of Canada. Mr. Bell is past Chairman of Waterloo Regional Police, Cambridge Memorial Hospital, Canada's Technology Triangle accelerator network and The Region of Waterloo prosperity counsel. Mr. Bell is a graduate of Western University Ivey School of Business, a Fellow of the institute of Chartered Accountants of Ontario, a graduate of the Institute of Directors Program of Canada and the owner's president program at Harvard and International marketing program at Oxford.

"We are delighted to have John Bell join the DelMar Board. In addition to his extensive financial and accounting background, John's operating experience will be invaluable as we continue to advance our business.  John's skill set and experience complement DelMar's focus on de
'/>"/>

SOURCE DelMar Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. DelMar Pharmaceuticals Announces $1.6 Million Closing in Private Placement
2. DelMar Pharmaceuticals Announces $1.0 Million Third Closing in Private Placement
3. DelMar Pharmaceuticals to Present Interim Clinical Data on VAL-083 in Refractory Glioblastoma at Society for Neuro-Oncology (SNO) Annual Meeting
4. Spring Bank Pharmaceuticals Closes $10.5 million Series A Financing to fund Phase I Clinical Trials in HCV-infected Patients
5. StockCall Insight into Eli Lilly, Bristol-Myers Squibb, Astex Pharmaceuticals and Raptor Pharmaceuticals
6. Valeant Pharmaceuticals Reports 2012 Fourth Quarter Financial Results
7. Vanda Pharmaceuticals to Present at the Cowen and Company 33rd Annual Health Care Conference
8. Bioassociate Announces Initiation of Coverage on KaloBios Pharmaceuticals, Inc.
9. Jazz Pharmaceuticals Announces Participation At Two Investor Conferences In March
10. Optimer Pharmaceuticals Board of Directors Appoints Board Chairman, Dr. Henry McKinnell, Chief Executive Officer
11. Arena Pharmaceuticals to Present at the Cowen and Company 33rd Annual Health Care Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2015)...  Astellas today announced topline results from the ... safety of intravenous (IV) and oral isavuconazole, commercially ... adults with candidemia and other invasive Candida ... the trial did not meet its primary endpoint ... patients at the end of IV therapy compared ...
(Date:7/29/2015)... 29, 2015  Unilife Corporation ("Unilife" or the "Company") ... manufacturer and supplier of injectable drug delivery systems, today ... provides the Company with flexibility and control to support ... signed an equity purchase agreement for up to $45 ... Chicago -based institutional investor, which provides ...
(Date:7/29/2015)... , July 29, 2015  According to data ... Services, the 2016 average monthly Medicare Part D premium ... far lower than was originally projected, the Pharmaceutical Care ... D program continues to be a bright spot in ... choices in each region and using cutting edge, cost-saving ...
Breaking Medicine Technology:Astellas Provides Update on Phase 3 Study Evaluating Isavuconazole in Patients with Candidemia and Other Invasive Candida Infections 2Astellas Provides Update on Phase 3 Study Evaluating Isavuconazole in Patients with Candidemia and Other Invasive Candida Infections 3Astellas Provides Update on Phase 3 Study Evaluating Isavuconazole in Patients with Candidemia and Other Invasive Candida Infections 4Astellas Provides Update on Phase 3 Study Evaluating Isavuconazole in Patients with Candidemia and Other Invasive Candida Infections 5Unilife Announces Multifaceted Financing Strategy 2Unilife Announces Multifaceted Financing Strategy 3Unilife Announces Multifaceted Financing Strategy 4Unilife Announces Multifaceted Financing Strategy 5
(Date:7/30/2015)... (PRWEB) , ... July 30, 2015 , ... Ross ... (UCF) College of Medicine as Assistant Professor of Plastic Surgery. This is Dr. ... Clevens has worked closely with the university, developing a strong presence and a valuable ...
(Date:7/30/2015)... ... July 30, 2015 , ... Using the latest online digital technologies, happiness expert ... ways to prevent and manage major depression. , “Suicide is 100% preventable. The problem ... through the cracks and die needlessly everyday,” says Walker. “I’m out to end suicide. ...
(Date:7/30/2015)... ... July 30, 2015 , ... Between 2012 and 2014 HIV infection rates rose ... on June 17th. Those untreated heroin use disorders share their needles and spread ... dirty needles throughout the community. Ultimately Florida’s HIV infection rates have bolstered to 23 ...
(Date:7/30/2015)... ... July 30, 2015 , ... The American Association ... Rosenberg’s announcement of the reinstitution of National Prescription Drug Take-Back Days. The 10th ... 10:00 AM to 2:00 PM local time. On the 26th, the DEA, with ...
(Date:7/30/2015)... ... July 30, 2015 , ... InventHelp, a leading inventor service ... personal-care device that makes it easy to apply lotion or medication to a hard-to-reach ... assistance when applying lotion or medication to the back, and provides thorough coverage. The ...
Breaking Medicine News(10 mins):Health News:Leading Melbourne Facial Plastic Surgeon Reappointed by UCF 2Health News:Leading Melbourne Facial Plastic Surgeon Reappointed by UCF 3Health News:Happiness Expert Develops Pioneering Online Tools for Sufferers of Major Depression, and Who may be Suicidal 2Health News:Happiness Expert Develops Pioneering Online Tools for Sufferers of Major Depression, and Who may be Suicidal 3Health News:HIV Rates Rise in S. Florida, Harbor Village Comments on Health News Florida's Recent Article 2Health News:HIV Rates Rise in S. Florida, Harbor Village Comments on Health News Florida's Recent Article 3Health News:AAPCC Supports National Prescription Drug Take-Back Day 2Health News:AAPCC Supports National Prescription Drug Take-Back Day 3Health News:InventHelp® Client Patents “My Back Buddy” – Device Could Apply Lotion to Hard-to-Reach Areas Easily 2
... ROCHESTER, Minn. A new study led by researchers ... institutions has found that patients with non-Hodgkin,s lymphoma who ... diagnosis had poorer overall survival, compared to patients who ... after accounting for clinical and demographic factors, and also ...
... known by its brand name Celebrex, can help prevent the ... and small intestine of children with an inheritable genetic disease ... but devastating disease, polyps begin forming in patients as young ... or even thousands. The disease carries a 100-percent lifetime ...
... males tying the knot with younger females, study found , THURSDAY, ... nine years their junior could be upping their odds of dying ... younger guy raises a woman,s risk of death by 20 percent, ... Demography . , Not that marrying much older men is ...
... ... unveil the Center for Biotechnology Education on Thursday, May 13, at its fifth ... County campus, 9601 Medical Center Drive in Rockville. , ... (PRWEB) May 13, 2010 -- The Johns Hopkins University’s Zanvyl ...
... ... owners have been scratching their heads trying to understand the new EPA “Lead-Based Paint ... , ... 13, 2010 -- MT2, LLC of Arvada, CO is providing eco-protective green technology to ...
... The Wistar Institute offer a new explanation for the persistent ... why melanoma remains the deadliest form of skin cancer. The ... melanoma cells behave like both conventional tumor cells and cancer ... issue of the journal Cell thatcontrary to other ...
Cached Medicine News:Health News:Lifestyle factors significantly impact survival of non-Hodgkin's lymphoma patients, study finds 2Health News:Lifestyle factors significantly impact survival of non-Hodgkin's lymphoma patients, study finds 3Health News:Lifestyle factors significantly impact survival of non-Hodgkin's lymphoma patients, study finds 4Health News:Women Who Marry Younger Men May Die Earlier 2Health News:Johns Hopkins to Unveil Center for Biotechnology Education 2Health News:Johns Hopkins to Unveil Center for Biotechnology Education 3Health News:Contractors Discover Relief from New EPA LBP RRP Rule 2Health News:Contractors Discover Relief from New EPA LBP RRP Rule 3Health News:Wistar scientists explain the persistence of melanoma through 'dynamic stemness' 2Health News:Wistar scientists explain the persistence of melanoma through 'dynamic stemness' 3
An environmentally-safe, CN-free lytic reagent designed for use on the Abbott CELL-DYN® 1800 three-part differential hematology analyzer....
... Retics is a 5-part differential control that ... Abbott CELL-DYN 3200, 3500, 3700 and 4000 ... nucleated red blood cells that can be ... The assay contains automated and manual reticulocyte ...
... hematology control for the Abbott CELL-DYN 3000, ... for the five-part white cell differential, as ... CELL-DYN 1600 and 1700. Open-vial stability is ... days. Para 12 Plus is packaged in ...
The technology in the LATITUDE system allows your doctor to get the same data from your device whether you are at home or in your doctor's office. This information transfer happens automatically....
Medicine Products: